Canine Parvovirus: Symptomatology and Prevention Guide: Interpreting Vomiting, Diarrhea, and Dehydration Characteristics

Canine Parvovirus (CPV) was first identified in the United States in 1997. Since its discovery, CPV has spread worldwide and remains one of the most severe and highly contagious diseases affecting dogs.

Etiology

Canine Parvovirus (CPV) belongs to the family Parvoviridae and the genus Parvovirus. CPV exhibits remarkable resistance to many physicochemical factors and common disinfectants. It can survive at 4–10 °C for up to six months, at 37 °C for two weeks, at 56 °C for 24 hours, and at 80 °C for 15 minutes. Under room temperature (approximately 20–25 °C), its infectivity decreases only slightly over three months. In feces, the virus can remain viable for several months to years. CPV resists ether, chloroform, and alcohols, but is sensitive to ultraviolet irradiation, formalin, sodium hypochlorite, and oxidizing agents.

Epidemiology

CPV primarily infects dogs—especially puppies—and is extremely contagious with high mortality. Although cases can occur year‑round, incidence peaks in winter and spring. Sudden changes in husbandry conditions, long‑distance transport, cold weather, and overcrowding all promote disease outbreaks.

Infected dogs are the main reservoir of the virus; large quantities are shed in vomitus, saliva, and feces. Recovered dogs may continue to excrete virus in their feces for extended periods. There is evidence that humans, lice, flies, and cockroaches can act as mechanical vectors. Transmission occurs via direct contact between healthy and infected or carrier dogs, or through ingestion of contaminated feed and water.

Pathogenesis

After oronasal exposure, CPV targets two primary cell types: intestinal epithelial cells and myocardial cells. Damage to intestinal cells leads to gastroenteric symptoms, while myocardial infection causes myocarditis, more commonly seen in puppies.

Clinical Presentation

Enteric Form

The incubation period is 7–14 days. Infection often follows environmental changes (e.g., newly purchased puppies), with bathing or dietary excess as triggers. Most cases manifest as enteritis; a minority develop myocarditis.

Initially, affected dogs exhibit lethargy and anorexia, with occasional fever, soft stools, or mild vomiting. This rapidly progresses to frequent vomiting and severe diarrhea. Feces are first gray, yellow, or milky, sometimes containing jelly‑like mucus, then evolve into malodorous, “tomato‑juice”‑like hemorrhagic stools. Dogs quickly become dehydrated and emaciated, with sunken eyes, unkempt coat, and non‑elastic skin. Extremities and mucous membranes may feel cool. Profound depression can lead to shock and death.

From mild initial signs to severe illness usually takes no more than two days, and the entire course typically lasts under one week.

Myocarditic Form

Myocarditis predominantly affects puppies aged 4–6 weeks. Often, there are no prodromal signs, or only mild diarrhea, followed by sudden collapse, vocalization, cyanotic mucous membranes, severe dyspnea, and a rapid, weak pulse with audible cardiac murmurs. Death frequently occurs within hours.

Diagnosis

Diagnosis is based on epidemiological history, clinical signs, and serological testing. CPV is characterized by rapid onset, strong infectivity, and explosive localized outbreaks, presenting primarily with vomiting, diarrhea, dehydration, and high mortality.

Serology commonly employs Enzyme‑Linked Immunosorbent Assay (ELISA), for which mature, high‑sensitivity test kits are available both domestically and internationally.

Treatment Principles

Clinical management focuses on supportive care combined with hyperimmune serum and monoclonal antibody therapy. Adult dogs have a high recovery rate; prognosis in puppies is guarded.

Prevention

Given CPV’s strong environmental resistance and prolonged survival, its contagiousness is formidable. Upon diagnosis, immediately isolate affected dogs and thoroughly disinfect contaminated kennels, feeding utensils, and transport vehicles. Recommended disinfectants include 2% sodium hydroxide (NaOH), bleaching powder, and potassium hypochlorite. Ultraviolet irradiation may be used, and facilities should remain unused for two weeks afterward.

Handlers should follow strict hygiene protocols and minimize movement to prevent indirect transmission.

Vaccination Protocol

Vaccination is the cornerstone of CPV prevention, though failures may occur due to vaccine quality or interference by maternal antibodies. Failures primarily result from inappropriate vaccine strain selection or high levels of maternal antibody.

Select vaccines from reputable manufacturers. The initial vaccination is generally administered at around 10 weeks of age; however, because puppies are susceptible before 10 weeks, a bivalent vaccine (CPV + canine distemper) may be given at 6 weeks to overcome maternal antibodies. A polyvalent vaccine (six‑in‑one) follows at 10 weeks, then every three weeks for two to three doses, with annual boosters thereafter.